Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-019959
Filing Date
2022-05-27
Accepted
2022-05-27 17:39:40
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3890
  Complete submission text file 0000899243-22-019959.txt   5328
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATAI LIFE SCIENCES N.V. 180 VARICK STREET NEW YORK NY 10014
Business Address
de Rosnay Alexis (Reporting) CIK: 0001860675 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 22979347